Two experimental Ebola drugs reduce mortality rate, according to preliminary data
Two experimental Ebola drugs significantly improve a patient’s chance of surviving the virus, according to preliminary data from a medical trial released Monday, offering fresh hope for stopping an outbreak of the disease that has gripped parts of the Democratic Republic of Congo for more than a year.
Of the 2,831 people who have been infected with Ebola in eastern Congo since Aug. 1, 2018, two-thirds—or 1,888—have died, according to the World Health Organization. But patients who received a cocktail of antibodies developed...
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Two experimental Ebola treatments being tested in Congo show promiseOutbreak of the virus spreading in eastern Democratic Republic of Congo since August 2018 is the world's second largest in history.
Baca lebih lajut »
Two Ebola drugs found to increase survival ratesScientists has come a step closer to an effective treatment for Ebola after two drugs in a clinical trial were found to significantly boost survival rates
Baca lebih lajut »
New drugs could cure Ebola, clinical trial suggests
Baca lebih lajut »
Early study results suggest 2 Ebola drugs saving livesTwo of four experimental Ebola drugs being tested in Congo appear to be saving lives, international health authorities announce.
Baca lebih lajut »
Ebola now curable after trials of drugs in DRC, say scientistsCongo results show good survival rates for patients treated quickly with antibodies. Ebola can no longer be called an incurable disease, scientists have said, after two of four drugs being trialled in the major outbreak in the Democratic Republic of the Congo were found to have significantly reduced
Baca lebih lajut »